Table 2.
Data on efficacy
| Characteristics | Patient 1a | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Initial PSA, before radical prostatectomyb | 36.00 | 15.30 | 12.51 | 9.94 |
| PSA at biochemical recurrence (baseline)b | 2.77 | 2.89 | 2.35 | 4.86 |
| M1 post-salvage radiotherapy PSAb | 2.39 | 2.19 | 2.19 | 2.70 |
| M4 post-salvage radiotherapy PSAb | 0.86 | 0.95 | 1.55 | 1.45 |
| PSA at last follow-upb | <0.03 | 0.23 | 1.59 | 0.5 |
| Month post-salvage radiotherapy | M23 | M15 | M17 | M15 |
M, month; PSA, prostate-specific antigen.
Patient who was diagnosed with a biochemical recurrence 11 months post-salvage radiation therapy.
All PSA values are given in nanograms per millilitre.